Angiogenesis, the formation of new blood vessels from existing vasculature, is essential for tissue growth, wound healing, and regeneration. Blood vessels deliver oxygen, nutrients, and growth factors while removing metabolic waste products. Impaired angiogenesis limits tissue repair capacity, whereas excessive angiogenesis occurs in cancer and other pathologic conditions (Carmeliet & Jain, 2011). Research peptides including BPC-157 and thymosin beta-4 (the parent protein of the TB-500 research peptide) have been studied for their effects on angiogenic signaling in cell and animal models.
How New Vessels Sprout
Sprouting angiogenesis follows a well-described sequence. Hypoxic tissue releases VEGF, which activates nearby endothelial cells. One cell becomes a migratory “tip cell” that extends filopodia toward the VEGF gradient, while neighboring “stalk cells” proliferate behind it to lengthen the sprout. Tip and stalk identities are coordinated by Notch signaling through the ligand Dll4. Sprouts then form a lumen, connect with other sprouts, and are stabilized by recruited pericytes and a new basement membrane (Potente et al., 2011). Endothelial cell migration itself depends on coordinated chemotactic, haptotactic, and mechanotactic signals (Lamalice et al., 2007).
VEGF and FGF: Master Regulators of Angiogenesis
Vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF) are primary angiogenic signals promoting endothelial cell proliferation, migration, and tube formation (Ferrara et al., 2003). VEGF signals through VEGFR1 and VEGFR2 on endothelial cells, activating PI3K/Akt and MEK/ERK pathways driving cell growth and survival. FGF signals through fibroblast growth factor receptors (FGFR) with similar downstream effects.
In experimental studies, BPC-157 has been linked to the VEGFR2 pathway. In cultured endothelial cells and a rat hind-limb ischemia model, it increased VEGFR2 expression and internalization and activated VEGFR2-Akt-eNOS signaling; blocking receptor internalization with dynasore prevented these effects, and VEGF-A expression itself was not increased (Hsieh et al., 2017). A review from the group that first described BPC-157 summarizes its reported effects on blood vessels after different types of experimental injury, including pathways involving NO, VEGF, and FAK (Seiwerth et al., 2014). Our BPC-157 research guide summarizes these preclinical findings.
Thymosin Beta-4 in Angiogenesis Studies
Thymosin beta-4 is a 43-amino-acid actin-sequestering protein. In cultured human umbilical vein endothelial cells, exogenous thymosin beta-4 increased cell-matrix attachment, proliferation, and tube formation, and it enhanced vascular sprouting in a coronary artery ring assay (Grant et al., 1999). In a rat full-thickness wound model, both topical and intraperitoneal thymosin beta-4 increased re-epithelialization, collagen deposition, and angiogenesis in the wound bed (Malinda et al., 1999). The TB-500 research peptide is based on this protein; see TB-500 10mg and our BPC-157 vs TB-500 comparison.
Endothelial Cell Functions Beyond Vessel Formation
Beyond structural tube formation, vascular endothelial cells produce angiocrine factors that influence tissue repair and metabolism. Endothelial-derived VEGF, FGF, and angiopoietins support fibroblast proliferation and collagen synthesis. Endothelial cells produce anticoagulant substances (thrombomodulin, protein C activation) maintaining blood fluidity, and anti-inflammatory factors reducing local inflammation. Endothelial dysfunction, characterized by impaired vasodilation (NO deficiency), increased permeability, and a pro-thrombotic phenotype, impairs tissue repair in experimental models, which is why endothelial function and NO signaling are common readouts in vascular repair studies.
How Angiogenesis Is Studied in the Lab
No single assay captures the whole process, so researchers usually combine several (Arnaoutova & Kleinman, 2010):
Endothelial tube formation. Endothelial cells plated on basement membrane extract form capillary-like networks within hours, a quick screen for pro- or anti-angiogenic activity.
Migration and proliferation assays. Scratch, transwell, and cell-count assays separate the individual steps of sprouting.
Aortic ring and spheroid sprouting. Explants or endothelial spheroids embedded in collagen or fibrin show three-dimensional sprout formation.
In vivo models. Matrigel plug assays, the chick chorioallantoic membrane (CAM), wound models, and hind-limb ischemia models measure vessel growth in living tissue, typically quantified by CD31 staining, vessel density, or perfusion imaging.
Key Findings from the Literature
Sprouting is a coordinated program. VEGF-guided tip cells, Notch-regulated stalk cells, and pericyte recruitment build new vessels (Potente et al., 2011).
BPC-157 has been linked to VEGFR2-Akt-eNOS signaling. The effect depended on receptor internalization in endothelial models (Hsieh et al., 2017).
Thymosin beta-4 promoted endothelial tube formation. It also enhanced sprouting in a coronary artery ring assay (Grant et al., 1999).
Thymosin beta-4 increased wound angiogenesis in rats. Re-epithelialization and collagen deposition also increased (Malinda et al., 1999).
Frequently Asked Questions
What is the difference between angiogenesis and vasculogenesis?
Angiogenesis is the growth of new vessels from existing ones. Vasculogenesis is the formation of vessels from endothelial progenitor cells, mainly during embryonic development.
Is the tube formation assay enough on its own?
No. It is fast and useful for screening, but it does not model sprouting through tissue, so results are usually confirmed with three-dimensional or in vivo assays.
How is new vessel growth quantified in tissue?
Typically by staining endothelial markers such as CD31 and measuring vessel density, along with perfusion measurements in ischemia models.
Is TB-500 the same as thymosin beta-4?
TB-500 is a research peptide based on thymosin beta-4. Much of the published angiogenesis literature used the full-length thymosin beta-4 protein, so results should not be assumed to transfer directly.
All BioSim peptides are supplied for laboratory research use only. They are not for human or veterinary use.
References
Arnaoutova I, Kleinman HK (2010). In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract. Nature protocols, 5(4), 628-35. PMID: 20224563 · DOI: 10.1038/nprot.2010.6
Carmeliet P, Jain RK (2011). Molecular mechanisms and clinical applications of angiogenesis. Nature, 473(7347), 298-307. PMID: 21593862 · DOI: 10.1038/nature10144
Ferrara N, Gerber HP, LeCouter J (2003). The biology of VEGF and its receptors. Nature medicine, 9(6), 669-76. PMID: 12778165 · DOI: 10.1038/nm0603-669
Grant DS, Rose W, Yaen C, et al. (1999). Thymosin beta4 enhances endothelial cell differentiation and angiogenesis. Angiogenesis, 3(2), 125-35. PMID: 14517430 · DOI: 10.1023/a:1009041911493
Hsieh MJ, Liu HT, Wang CN, et al. (2017). Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. Journal of molecular medicine (Berlin, Germany), 95(3), 323-333. PMID: 27847966 · DOI: 10.1007/s00109-016-1488-y
Lamalice L, Le Boeuf F, Huot J (2007). Endothelial cell migration during angiogenesis. Circulation research, 100(6), 782-94. PMID: 17395884 · DOI: 10.1161/01.RES.0000259593.07661.1e
Malinda KM, Sidhu GS, Mani H, et al. (1999). Thymosin beta4 accelerates wound healing. The Journal of investigative dermatology, 113(3), 364-8. PMID: 10469335 · DOI: 10.1046/j.1523-1747.1999.00708.x
Potente M, Gerhardt H, Carmeliet P (2011). Basic and therapeutic aspects of angiogenesis. Cell, 146(6), 873-87. PMID: 21925313 · DOI: 10.1016/j.cell.2011.08.039
Seiwerth S, Brcic L, Vuletic LB, et al. (2014). BPC 157 and blood vessels. Current pharmaceutical design, 20(7), 1121-5. PMID: 23782145 · DOI: 10.2174/13816128113199990421
Related Products: Products discussed in this article: BPC-157 10mg, TB-500 10mg. Our research peptides are 99%+ purity and third-party tested; available certificates of analysis are published on our COA page. For laboratory research use only.
Related Research: BPC-157 vs TB-500: Mechanisms, Research Applications, and Key Differences | Best Peptides for Tissue Repair Research
